Bactiguard Holding AB (publ) (BACTI-B) - Net Assets

Latest as of December 2025: Skr314.93 Million SEK ≈ $33.89 Million USD

Based on the latest financial reports, Bactiguard Holding AB (publ) (BACTI-B) has net assets worth Skr314.93 Million SEK (≈ $33.89 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr545.06 Million ≈ $58.66 Million USD) and total liabilities (Skr230.13 Million ≈ $24.77 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check BACTI-B asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr314.93 Million
% of Total Assets	57.78%
Annual Growth Rate	0.15%
5-Year Change	-41.84%
10-Year Change	-19.32%
Growth Volatility	66.65

Bactiguard Holding AB (publ) - Net Assets Trend (2008–2025)

This chart illustrates how Bactiguard Holding AB (publ)'s net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Bactiguard Holding AB (publ) for the complete picture of this company's asset base.

Annual Net Assets for Bactiguard Holding AB (publ) (2008–2025)

The table below shows the annual net assets of Bactiguard Holding AB (publ) from 2008 to 2025. For live valuation and market cap data, see market value of Bactiguard Holding AB (publ).

Year	Net Assets	Change
2025-12-31	Skr314.93 Million ≈ $33.89 Million	-4.08%
2024-12-31	Skr328.34 Million ≈ $35.33 Million	-7.03%
2023-12-31	Skr353.18 Million ≈ $38.01 Million	-28.75%
2022-12-31	Skr495.71 Million ≈ $53.35 Million	-8.45%
2021-12-31	Skr541.45 Million ≈ $58.27 Million	+45.02%
2020-12-31	Skr373.35 Million ≈ $40.18 Million	-3.45%
2019-12-31	Skr386.69 Million ≈ $41.61 Million	+4.28%
2018-12-31	Skr370.82 Million ≈ $39.91 Million	-4.21%
2017-12-31	Skr387.11 Million ≈ $41.66 Million	-0.83%
2016-12-31	Skr390.33 Million ≈ $42.01 Million	-6.50%
2015-12-31	Skr417.44 Million ≈ $44.92 Million	-19.52%
2014-12-31	Skr518.71 Million ≈ $55.82 Million	+268.00%
2013-12-31	Skr140.95 Million ≈ $15.17 Million	-2.52%
2012-12-31	Skr144.60 Million ≈ $15.56 Million	-23.03%
2011-12-31	Skr187.86 Million ≈ $20.22 Million	-35.80%
2010-12-31	Skr292.61 Million ≈ $31.49 Million	-7.81%
2009-12-31	Skr317.39 Million ≈ $34.16 Million	+3.31%
2008-12-31	Skr307.22 Million ≈ $33.06 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Bactiguard Holding AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 49104400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	Skr876.00K	0.28%
Other Comprehensive Income	Skr-1.44 Million	-0.46%
Other Components	Skr930.68 Million	295.52%
Total Equity	Skr314.93 Million	100.00%

Bactiguard Holding AB (publ) Competitors by Market Cap

The table below lists competitors of Bactiguard Holding AB (publ) ranked by their market capitalization.

Company	Market Cap
Global Fashion Group SA XETRA:GFG	$61.66 Million
Premium Snacks Nordic AB ST:SNX	$61.70 Million
Permianville Royalty Trust NYSE:PVL	$61.71 Million
The Hain Celestial Group Inc NASDAQ:HAIN	$61.74 Million
Seafco Public Company Limited BK:SEAFCO	$61.59 Million
Outset Medical Inc NASDAQ:OM	$61.59 Million
Careium AB ST:CARE	$61.52 Million
Thorney Opportunities Ltd AU:TOP	$61.51 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Bactiguard Holding AB (publ)'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 328,342,000 to 314,933,000, a change of -13,409,000 (-4.1%).
Net loss of 7,844,000 reduced equity.
Other comprehensive income decreased equity by 5,565,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Skr-7.84 Million	-2.49%
Other Comprehensive Income	Skr-5.57 Million	-1.77%
Total Change	Skr-	-4.08%

Book Value vs Market Value Analysis

This analysis compares Bactiguard Holding AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.05x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has increased from 0.00x to 2.05x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2009-12-31	Skr31738.90	Skr18.45	x
2010-12-31	Skr29260.80	Skr18.45	x
2011-12-31	Skr18785.70	Skr18.45	x
2012-12-31	Skr14460.00	Skr18.45	x
2013-12-31	Skr14095.20	Skr18.45	x
2014-12-31	Skr20.74	Skr18.45	x
2015-12-31	Skr12.53	Skr18.45	x
2016-12-31	Skr11.72	Skr18.45	x
2017-12-31	Skr11.62	Skr18.45	x
2018-12-31	Skr11.14	Skr18.45	x
2019-12-31	Skr11.61	Skr18.45	x
2020-12-31	Skr11.13	Skr18.45	x
2021-12-31	Skr15.45	Skr18.45	x
2022-12-31	Skr14.15	Skr18.45	x
2023-12-31	Skr10.08	Skr18.45	x
2024-12-31	Skr9.37	Skr18.45	x
2025-12-31	Skr8.99	Skr18.45	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Bactiguard Holding AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -2.49%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -3.63%
• Asset Turnover: 0.40x
• Equity Multiplier: 1.73x
Recent ROE (-2.49%) is above the historical average (-9.29%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2009	2.42%	6.04%	0.21x	1.95x	Skr-24.07 Million
2010	-8.46%	-21.06%	0.22x	1.84x	Skr-54.01 Million
2011	-8.15%	-349.27%	0.01x	3.46x	Skr-34.09 Million
2012	-26.53%	-29.73%	0.18x	4.87x	Skr-52.82 Million
2013	-2.42%	-2.69%	0.18x	5.09x	Skr-17.50 Million
2014	-18.32%	-87.16%	0.13x	1.56x	Skr-146.91 Million
2015	-6.35%	-20.17%	0.19x	1.62x	Skr-68.25 Million
2016	-6.88%	-22.61%	0.19x	1.62x	Skr-65.88 Million
2017	-0.84%	-2.20%	0.24x	1.62x	Skr-41.96 Million
2018	-4.03%	-9.95%	0.26x	1.58x	Skr-52.01 Million
2019	4.20%	8.79%	0.29x	1.66x	Skr-22.41 Million
2020	-10.28%	-22.28%	0.26x	1.81x	Skr-75.72 Million
2021	-10.85%	-34.68%	0.20x	1.57x	Skr-112.92 Million
2022	-10.67%	-23.65%	0.28x	1.63x	Skr-102.45 Million
2023	-39.18%	-67.84%	0.31x	1.87x	Skr-173.70 Million
2024	-9.08%	-12.24%	0.37x	2.00x	Skr-62.65 Million
2025	-2.49%	-3.63%	0.40x	1.73x	Skr-39.34 Million

Industry Comparison

This section compares Bactiguard Holding AB (publ)'s net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $147,618,697
Average return on equity (ROE) among peers: -30.92%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Bactiguard Holding AB (publ) (BACTI-B)	Skr314.93 Million	2.42%	0.73x	$61.64 Million
Acarix A/S (ACARIX)	$15.12 Million	-127.02%	0.21x	$33.84 Million
Arcoma AB (ARCOMA)	$48.66 Million	5.27%	0.68x	$11.55 Million
BICO Group AB (BICO)	$2.31 Million	0.00%	2.47x	$159.82 Million
Boule Diagnostics AB (BOUL)	$295.74 Million	7.87%	0.93x	$14.38 Million
CellaVision AB (CEVI)	$887.58 Million	17.25%	0.23x	$311.10 Million
Clinical Laserthermia Systems AB (publ) (CLS-B)	$26.09 Million	-70.24%	0.12x	$11.57 Million
Chordate Medical Holding AB (CMH)	$25.64 Million	-77.06%	0.22x	$29.05K
C-Rad AB (publ) (CRAD-B)	$29.82 Million	-34.38%	0.50x	$86.08 Million
Duearity AB (DEAR)	$-2.39 Million	0.00%	0.00x	$331.97K

About Bactiguard Holding AB (publ)

ST:BACTI-B Sweden Medical Devices

Market Cap

$61.64 Million

Skr572.76 Million SEK

Market Cap Rank

#21069 Global

#379 in Sweden

Share Price

Skr18.45

Change (1 day)

+2.50%

52-Week Range

Skr14.75 - Skr37.90

All Time High

Skr205.00